179 related articles for article (PubMed ID: 3263998)
1. Simultaneous colloidal gold immunoelectronmicroscopy labeling of CD1a, HLA-DR, and CD4 surface antigens of human epidermal Langerhans cells.
De Panfilis G; Manara GC; Ferrari C; Torresani C
J Invest Dermatol; 1988 Dec; 91(6):547-52. PubMed ID: 3263998
[TBL] [Abstract][Full Text] [Related]
2. Regional development of Langerhans cells and formation of Birbeck granules in human embryonic and fetal skin.
Fujita M; Furukawa F; Horiguchi Y; Ueda M; Kashihara-Sawami M; Imamura S
J Invest Dermatol; 1991 Jul; 97(1):65-72. PubMed ID: 1711549
[TBL] [Abstract][Full Text] [Related]
3. CD-1 (T6), HLA-DR-expressing cells, presumably Langerhans cells, in nasal mucosa.
Fokkens WJ; Vroom TM; Rijntjes E; Mulder PG
Allergy; 1989 Apr; 44(3):167-72. PubMed ID: 2469344
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometrically-sorted residual HLA-DR+T6+ Langerhans cells in topical steroid-treated human skin express normal amounts of HLA-DR and CD1a/T6 antigens and exhibit normal alloantigen-presenting capacity.
Ashworth J; Kahan MC; Breathnach SM
J Invest Dermatol; 1989 Feb; 92(2):258-62. PubMed ID: 2783952
[TBL] [Abstract][Full Text] [Related]
5. Langerhans cells expressing HLA-DQ, HLA-DR and T6 antigens in normal oral mucosa and lichen planus.
Chou MJ; Daniels TE
J Oral Pathol Med; 1989 Dec; 18(10):573-6. PubMed ID: 2621652
[TBL] [Abstract][Full Text] [Related]
6. T-cell response to purified protein derivative after removal of Langerhans' cells from epidermal cell suspensions containing keratinocytes expressing class II transplantation antigens.
Tjernlund U; Scheynius A; Johansson C; Hagforsen E; Nilsson H
Scand J Immunol; 1988 Dec; 28(6):667-73. PubMed ID: 3266023
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous detection of T6 and HLA-DR antigens distinguishes three cell subpopulations in dispersed normal human epidermal cells.
Dezutter-Dambuyant C; Faure M; Schmitt D; Laquoi C; Thivolet J
Immunol Lett; 1984; 7(4):203-7. PubMed ID: 6423529
[TBL] [Abstract][Full Text] [Related]
8. HLA-DR-positive leucocyte subpopulations in human skin include dendritic cells, macrophages, and CD7-negative T cells.
Davis AL; McKenzie JL; Hart DN
Immunology; 1988 Dec; 65(4):573-81. PubMed ID: 3065220
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical study of normal skin of HIV-1-infected patients shows no evidence of infection of epidermal Langerhans cells by HIV.
Kanitakis J; Marchand C; Su H; Thivolet J; Zambruno G; Schmitt D; Gazzolo L
AIDS Res Hum Retroviruses; 1989 Jun; 5(3):293-302. PubMed ID: 2471543
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid upregulates human Langerhans cell antigen presentation and surface expression of HLA-DR and CD11c, a beta 2 integrin critically involved in T-cell activation.
Meunier L; Bohjanen K; Voorhees JJ; Cooper KD
J Invest Dermatol; 1994 Dec; 103(6):775-9. PubMed ID: 7798614
[TBL] [Abstract][Full Text] [Related]
11. Human gingival Langerhans cells stimulate allogeneic lymphocytes: requirement for MHC class II antigens.
Walsh LJ; Seymour GJ; Powell RN
J Periodontol; 1990 Jun; 61(6):328-33. PubMed ID: 2366140
[TBL] [Abstract][Full Text] [Related]
12. Rapid purification of human Langerhans cells using paramagnetic microbeads.
Simon JC; Dittmar HC; de Roche R; Wilting J; Christ B; Schöpf E
Exp Dermatol; 1995 Jun; 4(3):155-61. PubMed ID: 7551563
[TBL] [Abstract][Full Text] [Related]
13. Recent advances of ultrastructural immunocytochemistry of epidermal Langerhans cells.
Schmitt D; Dezutter-Dambuyant C; Faure M; Thivolet J
Br J Dermatol; 1985 Jul; 113 Suppl 28():2-9. PubMed ID: 3925979
[TBL] [Abstract][Full Text] [Related]
14. Differing cell surface distribution of human leukocyte antigen-DR molecules on epidermal Langerhans cells and eccrine duct cells.
Imayama S; Yashima Y; Hori Y
J Histochem Cytochem; 1992 Aug; 40(8):1191-6. PubMed ID: 1619281
[TBL] [Abstract][Full Text] [Related]
15. Expression and function of B7 on human epidermal Langerhans cells.
Symington FW; Brady W; Linsley PS
J Immunol; 1993 Feb; 150(4):1286-95. PubMed ID: 7679425
[TBL] [Abstract][Full Text] [Related]
16. Ontogeny of Langerhans cells: phenotypic differentiation from the bone marrow to the skin.
de Fraissinette A; Dezutter-Dambuyant C; Schmitt D; Thivolet J
Dev Comp Immunol; 1990; 14(3):335-46. PubMed ID: 1698667
[TBL] [Abstract][Full Text] [Related]
17. Dual expression of the cell-surface antigens HLA-DR and CD1 (T6) by Langerhans cells in human buccal mucosa and skin.
Cruchley AT; Speight PM; Williams DM
Arch Oral Biol; 1987; 32(11):849-53. PubMed ID: 2452627
[TBL] [Abstract][Full Text] [Related]
18. PUVA therapy decreases HLA-DR+ CDIa+ Langerhans cells and epidermal cell antigen-presenting capacity in human skin, but flow cytometrically-sorted residual HLA-DR+ CDIa+ Langerhans cells exhibit normal alloantigen-presenting function.
Ashworth J; Kahan MC; Breathnach SM
Br J Dermatol; 1989 Mar; 120(3):329-39. PubMed ID: 2469456
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous populations of class II MHC+ cells in human dermal cell suspensions. Identification of a small subset responsible for potent dermal antigen-presenting cell activity with features analogous to Langerhans cells.
Meunier L; Gonzalez-Ramos A; Cooper KD
J Immunol; 1993 Oct; 151(8):4067-80. PubMed ID: 8409386
[TBL] [Abstract][Full Text] [Related]
20. Fc gamma RII/CD32-negative human Langerhans cells may be responsible for the immunostimulatory activity of freshly isolated epidermal cells.
Schmitt DA; Bieber T; Cazenave JP; Hanau D
Cell Immunol; 1992 Apr; 140(2):507-12. PubMed ID: 1371951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
